BikdeliBChatterjeeSDesaiNR, et al.Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol2017;
70: 1587–1597.
2.
DecoususHLeizoroviczAParentF, et al.
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med1998;
338: 409–415.
3.
KonstantinidesSV.The elusive evidence for inferior vena cava filters to prevent pulmonary embolism. J Am Coll Cardiol2017;
70: 1598–1600.
4.
GreenfieldLJ.The PREPIC Study Group.
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study. Perspect Vasc Surg Endovasc Ther2006;
18: 187–188.
5.
KearonCAklEAComerotaAJ, et al.
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;
141: e419S–e496S.
6.
RajasekharA.Inferior vena cava filters: current best practices. J Thromb Thrombolysis2015;
39: 315–327.
7.
TritschlerTKraaijpoelNLe GalG, et al.
Venous thromboembolism: advances in diagnosis and treatment. JAMA2018;
320: 1583–1594.
8.
FerrisEJMcCowanTCCarverDK, et al.
Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology1993;
188: 851–856.
9.
MismettiPLaporteSPellerinO, et al; PREPIC2 Study Group.
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA2015;
313: 1627–1635.
